Depression is an early disease manifestation in lupus-prone MRL/lpr mice

被引:66
|
作者
Gao, Hua-Xin [2 ]
Campbell, Sean R. [2 ]
Cui, Min-Hui [3 ]
Zong, Pu [3 ]
Hee-Hwang, Jong [3 ]
Gulinello, Maria [4 ]
Putterman, Chaim [1 ,2 ]
机构
[1] Albert Einstein Coll Med, Div Rheumatol, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[3] Albert Einstein Coll Med, Magnet Resonance Res Ctr, Bronx, NY 10461 USA
[4] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA
关键词
Systemic Lupus Erythematosus; Neuropsychiatric lupus; Anti-DNA antibodies; Depression; MRL-LPR MICE; MAGNETIC-RESONANCE-SPECTROSCOPY; RIBOSOMAL-P ANTIBODIES; AUTOREACTIVE B-CELLS; ELEVATED-PLUS-MAZE; PSYCHIATRIC MANIFESTATIONS; NEUROPSYCHIATRIC MANIFESTATIONS; ANTIPHOSPHOLIPID SYNDROME; PROTEIN AUTOANTIBODIES; COGNITIVE IMPAIRMENT;
D O I
10.1016/j.jneuroim.2008.11.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Many lupus patients develop neuropsychiatric manifestations, including cognitive dysfunction, depression, and anxiety. However, it is not clear if neuropsychiatric lupus is a primary disease manifestation, or is secondary to non-CNS disease. We found that MRL/lpr lupus-prone mice exhibited significant depression-like behavior already at 8 weeks of age, despite normal visual working memory, locomotor coordination and social preference. Moreover, depression was significantly correlated with titers of autoantibodies against DNA, NMDA receptors and cardiolipin. Our results indicate that lupus mice develop depression and CNS dysfunction very early in the course of disease, in the absence of substantial pathology involving other target organs. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:45 / 56
页数:12
相关论文
共 50 条
  • [41] Therapeutic effects of soluble human leukocyte antigen G2 isoform in lupus-prone MRL/lpr mice
    Watanabe, Hiroshi
    Kuroki, Kimiko
    Yamada, Chisato
    Saburi, Yukari
    Maeda, Naoyoshi
    Maenaka, Katsumi
    HUMAN IMMUNOLOGY, 2020, 81 (04) : 186 - 190
  • [42] SYNERGISTIC EFFECTS OF DIFLUOROMETHYLORNITHINE (DFMO) AND CYCLOPHOSPHAMIDE (CYTOXAN) ON PROLONGING THE MEDIAN LIFE-SPAN OF LUPUS-PRONE MRL-LPR/LPR MICE
    THOMAS, TJ
    GUNNIA, UB
    MANN, RA
    THOMAS, T
    AMENTA, PS
    ALLI, KA
    SEIBOLD, JR
    CLINICAL RESEARCH, 1991, 39 (02): : A310 - A310
  • [43] Lack of MASP-1 results in delayed onset of albuminuria and prolonged survival in lupus-prone MRL/lpr mice
    Machida, Takeshi
    Monoe, Hiroto
    Ishida, Yumi
    Fujita, Teizo
    Sekine, Hideharu
    IMMUNOBIOLOGY, 2023, 228 (05) : 42 - 42
  • [44] Nucleolin as one of the earliest targets of autoantibodies produced in NZB/W Fl and MRL/lpr lupus-prone mice.
    Hirata, D
    Iwamoto, M
    Okazaki, H
    Kano, S
    Minota, S
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S254 - S254
  • [45] Anti-high Mobility Group Box 1 Antibody Ameliorates Albuminuria in MRL/lpr Lupus-Prone Mice
    Watanabe, Haruki
    Watanabe, Katsue S.
    Liu, Keyue
    Hiramatsu, Sumie
    Zeggar, Sonia
    Katsuyama, Eri
    Tatebe, Noriko
    Akahoshi, Akiya
    Takenaka, Fumiaki
    Hanada, Takahisa
    Akehi, Masaru
    Sasaki, Takanori
    Sada, Ken-ei
    Matsuura, Eiji
    Nishibori, Masahiro
    Wada, Jun
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2017, 6 : 31 - 39
  • [46] Metformin improves renal injury of MRL/lpr lupus-prone mice via the AMPK/STAT3 pathway
    Chen, Xiao-Cui
    Wu, Dan
    Wu, Hong-Luan
    Li, Hui-Yuan
    Yang, Chen
    Su, Hong-Yong
    Liu, Ze-Jian
    Huang, Xiao-Rong
    Lu, Xing
    Huang, Li-Feng
    Zhu, Shao-Ping
    Pan, Qing-Jun
    An, Ning
    Liu, Hua-Feng
    LUPUS SCIENCE & MEDICINE, 2022, 9 (01):
  • [47] MHC class I polymorphism in lupus-prone MRL/Mp mice
    Peng, SL
    Craft, J
    IMMUNOGENETICS, 1996, 44 (05) : 407 - 408
  • [48] Immunoglobulin heavy, chain revision in lupus-prone MRL mice.
    Klonowski, KD
    Monestier, M
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S283 - S283
  • [49] The effect of targeted delivery of anti-TNF-α oligonucleotide into CD169+ macrophages on disease progression in lupus-prone MRL/lpr mice
    Huang, Zhen
    Zhang, Zhengping
    Zha, Yinhe
    Liu, Jialin
    Jiang, Yucui
    Yang, Yang
    Shao, Juan
    Sun, Xulun
    Cai, Xin
    Yin, Yuan
    Chen, Jiangning
    Dong, Lei
    Zhang, Junfeng
    BIOMATERIALS, 2012, 33 (30) : 7605 - 7612
  • [50] Peptidylarginine Deiminase Inhibition Mitigates NET Formation and Protects Against Kidney, Skin, and Vascular Disease in Lupus-Prone MRL/Lpr Mice.
    Knight, Jason S.
    Subramanian, Venkataraman
    O'Dell, Alexander A.
    Yalavarthi, Srilakshmi
    Zhao, Wenpu
    Smith, Carolyne K.
    Hodgin, Jeffrey B.
    Thompson, Paul Ryan
    Kaplan, Mariana J.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S281 - S281